Archive

Category: Chris Garabedian

INVEST Digital Health preview: The Next Phase of Digital Health Investment

INVEST Digital Health is set for September 20-23, and held in collaboration with Medical Alley. It brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.

Perceptive Advisors closes $515M fund to fuel more early-stage biotech startups

Perceptive Advisors has $515 million for its second fund investing in biotech startups. Portfolio Manager Chris Garabedian says Perceptive Xontogeny Ventures Fund II is looking to make Series A investments in early-stage companies with assets that can show a path to clinical testing.